BP
Biophytis S.A.
BPTSY · OTC
$0.25 +0.00% (+$0.00)
Market Cap 91.7K €
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.29
16.0% upside
Current Price
$0.25
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BPTSY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 2,242.74%
Asset turnover 0.00x
ROA 150.38%
Debt
0 /100
High Current ratio 0.25x
Int. coverage -5.56x
Debt/Equity N/A
Stability
68 /100
Stable Beta 0.90x
Profitable years 0
EPS volatility 25.62%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BPTSY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stanislas Veillet
Employees
19
Headquarters
Paris
Upcoming events
03 MAR
Earnings
Upcoming earnings report